EMEA-000480-PIP01-08-M14
Key facts
Invented name |
Brilique
|
Active substance |
Ticagrelor
|
Therapeutic area |
|
Decision number |
P/0175/2021
|
PIP number |
EMEA-000480-PIP01-08-M14
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Prevention of thromboembolic events
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
AstraZeneca AB
Tel. +46 8553 27591 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000480-PIP01-08-M14
|
Compliance opinion date |
25/06/2021
|
Compliance outcome |
positive
|